Managing complex perianal disease after anti-TNF failure: Where to go next?
Ontology highlight
ABSTRACT: Crohn's disease is a chronic inflammatory bowel disease that affects various intestinal segments and can involve the perianal region. Although anti-tumor necrosis factor (TNF) agents have revolutionized the management of Crohn's disease and improved the prognosis for patients with perianal Crohn's disease (pCD), their long-term effectiveness is limited: over 60% of patients relapse after one year of maintenance therapy. In recent years, significant advances have been made in the treatment of complex perianal fistulas after anti-TNF failure. Concomitant treatment with antibiotics and immunosuppressants improves the effectiveness of anti-TNF agents. Therapeutic drug monitoring and dose adjustment of anti-TNF therapy (targeting a higher trough level) might also improve treatment response. Nov
SUBMITTER: Yzet C
PROVIDER: S-EPMC8784625 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA